Turkish Journal of Medical Sciences
Volume 48

Number 4

Article 17

1-1-2018

Detection of the differences in the apparent diffusion coefficient
values in differenthistopathological types of malignant breast
lesions and comparison of cellular region/stroma ratio and
histopathological results
NEVİN KÖREMEZLİ KESKİN
PINAR BALCI
IŞIL BAŞARA AKIN
ESRA YAVUZ GÜRKAN
ALİ İBRAHİM SEVİNÇ

See next page for additional authors
Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KESKİN, NEVİN KÖREMEZLİ; BALCI, PINAR; AKIN, IŞIL BAŞARA; GÜRKAN, ESRA YAVUZ; SEVİNÇ, ALİ
İBRAHİM; DURAK, MERİH GÜRAY; and DANYELİ, AYÇA ERŞEN (2018) "Detection of the differences in the
apparent diffusion coefficient values in differenthistopathological types of malignant breast lesions and
comparison of cellular region/stroma ratio and histopathological results," Turkish Journal of Medical
Sciences: Vol. 48: No. 4, Article 17. https://doi.org/10.3906/sag-1801-89
Available at: https://journals.tubitak.gov.tr/medical/vol48/iss4/17

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Detection of the differences in the apparent diffusion coefficient values in
differenthistopathological types of malignant breast lesions and comparison of
cellular region/stroma ratio and histopathological results
Authors
NEVİN KÖREMEZLİ KESKİN, PINAR BALCI, IŞIL BAŞARA AKIN, ESRA YAVUZ GÜRKAN, ALİ İBRAHİM
SEVİNÇ, MERİH GÜRAY DURAK, and AYÇA ERŞEN DANYELİ

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol48/iss4/17

Turkish Journal of Medical Sciences

Turk J Med Sci
(2018) 48: 817-825
© TÜBİTAK
doi:10.3906/sag-1801-89

http://journals.tubitak.gov.tr/medical/

Research Article

Detection of the differences in the apparent diffusion coefficient values in different
histopathological types of malignant breast lesions and comparison of cellular region/
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Background/aim: This study aimed to compare the apparent diffusion coefficient (ADC) values of malignant breast lesions with different
histopathological types on diffusion-weighted imaging (DWI) and the cellular region/stroma (CR/S) ratio and histopathological results.
Materials and methods: Breast diffusion-weighted magnetic resonance findings of 59 patients were retrospectively analyzed for
malignant breast lesions. The CR/S ratio was calculated using breast wide-excisional biopsy or mastectomy specimens.
Results: Receiver operating characteristic analysis was performed for malignant lesions and subtypes. An ADC threshold of 1.260 ×
10–3 mm2/s was set to detect invasive ductal carcinoma with 80.8% sensitivity and 81.4% specificity. An ADC threshold of 1.391 × 10–3
mm2/s was set to detect invasive lobular carcinoma lesions with 88.2% sensitivity and 79.5% specificity. The ADC value for lesions with
low CR/S ratio (n = 21) was 1.135 ± 0.429 × 10–3 mm2/s and it was 1.155 ± 0.429 × 10–3 mm2/s in the high CR/S ratio group (n = 18).
Conclusion: ADC value calculation does not seem to be used as an alternative for histopathological detection, which is the gold standard
for the differentiation of subtypes of malignant breast cancer. In addition, since there is a positive correlation between CR/S ratio and
ADC values, it may be a strong marker to evaluate the stromal component of lesions.
Key words: Diffusion-weighted imaging, cellular region/stroma ratio, magnetic resonance imaging

1. Introduction
Magnetic resonance imaging (MRI) is a radiological
method that has started to be used increasing frequently
in the evaluation of breast lesions (1,2). MRI has high
contrast resolution. Thanks to technical developments,
rapid sequences and functional examinations can be
performed. Diffusion weighted imaging (DWI) is one
of these rapid MRI sequences (3). Diffusion occurs as a
result of the movements driven by the intrinsic molecular
kinetic energy. The magnitude of the gradient applied in
diffusion measurement is represented with the “b” value,
a parameter that indicates the strength and timing of
the gradient in s/mm2. The apparent diffusion coefficient
(ADC) within tissue can only be measured when there
are a minimum of two different “b” values. The most
commonly used sequence in diffusion MRI is the single-

shot echo planar imaging (EPI) sequence (3,4). Many
clinical studies have shown that DWI has high sensitivity
in the evaluation of breast lesions and differentiation of
the malignant and the benign. Ei Khouli et al. pointed
out an increase in the diagnostic accuracy by combining
DWI and the conventional MRI (3.0 T) (5). ADC values
obtained from any lesion show parallelism with the tumor
tissue cellularity (6). Thanks to this property, it contributes
to characterization of the malignant lesions in the
preoperative phase and diagnosis of the recurrent tumors
in the postoperative phase. Malignant breast tumors show
areas of high cellularity and low ADC values (7,8).
This study aimed to identify the abnormal
signal alterations detected using DWI in different
histopathological types of malignant breast lesions, to
detect the differences in the ADC values, and to compare
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these values with the cellular region/stroma (CR/S) ratio
and histopathological results.
2. Materials and methods
Before the present study, permission was obtained from
the ethics committee of the faculty. Informed patient
consent was obtained before inclusion in the study and the
study was conducted in accordance with the principles of
the Declaration of Helsinki.
2.1. Study population
Images of 59 patients (age range: 25–76 years) who
underwent routine breast MRI examination including
diffusion weighted sequences in August 2011–November
2013 were analyzed retrospectively. Study inclusion
criteria were to have mass size of ≥1.5 × 1.5 cm and to have
Breast Imaging Reporting and Data Systems (BI-RADS)
Category 4, 5, or 6 lesions detected in the breast imaging.
Measurements were also made on the contralateral normal
breast tissues of the patients. MRI scans of premenopausal
patients were performed in the 2nd week of their
menstrual cycle. Patients with cardiac pacemakers that
contraindicate MRI and with surgical clips or prostheses
that are incompatible with MRI were excluded from the
study. In addition, patients who had lesion diameter of
<1.5 cm, who underwent excisional or incisional biopsy
before MRI, who received chemotherapy or radiation
therapy before MRI, and those with artifacts with MRI
were also excluded from the study.
2.2. MRI and DWI evaluation
All patients underwent MRI using a 1.5 T MRI device
(Gyroscan Achieva, Philips, ACS-NT). Fat-suppressed
TSE T1 and T2 weighted axial, gradient echo T1 weighted
axial, contrast gradient echo T1 weighted dynamic, and
late-phase axial sequences were performed as the routine
breast sequences by using a standard breast coil in the
prone position with a 40 cm field of view (FOV). Images
with a slice thickness of 3 mm and slice spacing of 0.3 mm
(TR: 515 m/s, TE: 8 m/s, matrix: 512 × 512) were obtained
for the precontrast TSE T1 SPIR-weighted images. Before
entry into the MRI device, a catheter was inserted into an
antecubital vein of each patient for injection of the contrast
agent. For dynamic examination, 8 images were produced
for each section in the axial plane at 30-s intervals using T1weighted FFE sequences with TR: 15 m/s, TE: 5 m/s, lying
angle: 20°, matrix: 256 × 256, slice thickness: 4 mm, and
slice spacing: 0.4 mm. Gadolinium-based contrast agent
(a dose of 0.1–0.2 mmol/kg) was manually intravenously
administered in 20 s.
By using the standard subtraction program
integrated into the Philips MRI console, the precontrast
dynamic images were extracted from the corresponding
postcontrast dynamic images in pixels to obtain the
subtract series, which contributed to the revealing of the
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contrasting profile. Initial dynamic serial images were
transferred to the workstation (EasyVision-M, Philips,
ACS-NT, USA) in a digital environment to draw the timesignal intensity curves of the lesions. In addition, after the
patients were asked to hold their breath before the injection
of the contrast agent, DWI was performed in the axial plane
using the single-shot echo planar spin-echo sequence with
the following parameters: TR/TR: 5250/90 m/s, matrix: 128
× 128, FOV: 35 cm, slice thickness: 3 mm, and slice spacing:
1.5 mm. Both breasts were examined in approximately 200
slices. For each slice, three different “b” values of “b = 100
s/mm2”, “b = 500 s/mm2”, and “b = 1000 s/mm2” were used.
Diffusion gradients were applied simultaneously in three
perpendicular directions (x, y, z). Each DWI sequence
was acquired in approximately 4 min. A diffusion group
consisting of five images for each slice obtained was created
using anisotropic and isotropic (trace) diffusion slices
along the respective directions of b = 0, x, y, z. ADC values
were automatically calculated using a specific program of
the MRI console to create ADC maps and all images were
transferred to the digital archiving system (PACS: Picture
Archiving and Communication System).
2.3. Data assessment
All conventional sequences and DWI scans were assessed
by two radiologists with 4 and 5 years of experience,
respectively. These assessments were based on the presence
and prevalence of the breast lesions with abnormally
contrast enhancement, presence/absence of restricted
diffusion detected via high signaling regions in the DWI
scans of the breast tissues accounting for the lesions (b =
1000 s/mm2), and the values measured in the ADC map.
ADC values of the contralateral normal breast tissues
were considered for the control group. Necrotic and cystic
components of the lesions and, for the normal breast,
adipose tissue measurement area were excluded during
the ADC measurements. ADC values were measured three
times each from the nonnecrotic and noncystic parts of
the lesions to calculate the arithmetic mean. The ADC
value was calculated via the standard region of interest
with the standard deviation as a measure of variation.
Measurements made in this scope were then compared
with the pathological result of the lesion. Histopathological
results were accepted as the “gold standard”.
2.4. Histopathological evaluation
To compare the ADC and CR/S ratio, hematoxylin and
eosin-stained tumor sections of the breast wide excision
or mastectomy materials were reexamined and a total
of five images were obtained: two from the most cellular
region, one from the most peripheral and one from the
least cellular region, and one from the transition region
between these two regions (midcellular region), all under
20× magnification (Olympus DP70, Olympus Optical Co.
Ltd., Japan).
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In this study, all histopathology images were
segmented manually by pathologists using a software
tool (Arachne by Netform Engineering, İzmir, Turkey,
http://www.netformvision.com/arachne.asp)
(accessed
16.08.2013). The Arachne software tool was developed in
C++ programming language for the Windows operating
system. Arachne allows pathologists to label each grid
square as various types (tumor, stroma, lumen, etc.) by
mouse clicks and calculates the requested label ratios of
any kind and other digital features using the input label
grid information. Following manual intervention, digital
features are automatically calculated by Arachne using the
provided data. In the scope of this study, the cellular and
extracellular regions were marked and boxed in different
colors with the help of this program. The diameter of each
box was defined as 80 µm2 in the design phase of the study
so as to ensure that it could cover at least one cell. A third
color was used to mark the artificial spaces of the tissue,
which were then excluded from the calculations. The
ratio of the selected regions (the cellular and extracellular
regions) to each other was automatically calculated using
the Arachne software. The procedure was repeated for each
image. The arithmetic mean of the five images of the same
individual case was calculated to obtain the final values.
The procedure took approximately 20 min for each case.
The cases with Tru-Cut biopsy specimens were excluded
from the study since they did not have a tumor site large
enough to obtain five images under 20× magnification.
2.5. Statistical analysis
Statistical analysis was performed using SPSS 15.0 for
Windows (SPSS Inc., Chicago, IL, USA). The Mann–
Whitney U test was used for group comparisons of the
measurable variables and two-tailed variant analysis for the
repeated measurements of the ADC values. The Spearman
correlation test and kappa consistency test were used to
compare the counted variables. The receiver operating
characteristic (ROC) curve was drawn to analyze the
validity and reliability of the mean ADC values of ductal
and lobular breast lesions due to their high incidence. The
t-test was used to estimate the statistical significance level
of the mean ADC values in distinguishing both lesions.
ADC measurement values of both observers were analyzed
via correlation analysis. Statistical significance was set at P
< 0.05.
3. Results
The measurements of the malignant breast lesions and
normal breast tissues (b = 1000 s/mm2) produced mean
ADC values of 1.725 ± 0.508 × 10–3 mm2/s for normal
breast tissues and 1.098 ± 0.410 × 10–3 mm2/s for malignant
breast lesions. The mean ADC value was calculated to
be 1.078 ± 0.294 × 10–3 mm2/s for the invasive ductal
carcinoma (IDC) lesions (n = 26), 1.151 ± 0.340 × 10–3

mm2/s for the invasive lobular carcinoma (ILC) lesions
(n = 17), 0.783 ± 0.188 × 10–3 mm2/s for the IDC + ILC
lesions (n = 7), 1.241 × 10–3 mm2/s for the IDC + invasive
cribriform carcinoma (ICC) lesion (n = 1), 1.075 ± 0.154 ×
10–3 mm2/s for the ICC lesions (n = 2), 0.845 × 10–3 mm2/s
for the medullary carcinoma lesion (n = 1), 2.568 ± 0.165
× 10–3 mm2/s for the mucinous carcinoma lesions (n =
2), 0.927 × 10–3 mm2/s for the tubular carcinoma (ITC)
lesion (n = 1), 0.754 × 10–3 mm2/s for the Langerhans-cell
histiocytosis (LCH) lesion (n = 1), and 0.650 × 10–3 mm2/s
for the lymphoma lesion (n = 1). Separate ROC analyses
were performed for the malignant lesions, IDC lesions,
and ILC lesions. Accordingly, the threshold ADC value to
differentiate the malignant tissue from the normal breast
tissue was set at 1.260 × 10–3 mm2/s, with 79.7% sensitivity
and 81.4% specificity (area under curve [AUC] = 85.7%).
Similarly, the threshold ADC value for the detection of
IDC lesions was set at 1.260 × 10–3 mm2/s, with 80.8%
sensitivity and 81.4% specificity and the threshold ADC
value for the detection of ILC lesions was set at 1.391 × 10–3
mm2/s, with 88.2% sensitivity and 79.5% specificity (AUC
= 87.2% and 84.3%, respectively) (Table 1; Figure 1). Since
the AUC and the sensitivity and specificity values were
high, the threshold ADC value had high discriminatory
power. The results of the t-test conducted to compare the
IDC and ILC values produced no statistically significant
difference in the mean ADC values of the two groups (P
= 0.45). Correlation between the two observers in the
measurements of the ADC maps at b = 100, 500, and 1000
s/mm2 of the lesion (the localization and size of which was
detected in MRI on the T1-weighted sequences) was tested
by the correlation test and found to be consistent with P <
0.001.
Evaluations of the pathological grading of the lesions
produced mean ADC values of 1.462 ± 0.699 × 10–3 mm2/s
for the grade 1 lesions (n = 8), 1.014 ± 0.280 × 10–3 mm2/s
for the grade 2 lesions (n = 27), and 1.104 ± 0.362 ×
10–3 mm2/s for the grade 3 lesions (n = 22). Pathological
grading of two lesions, one diagnosed as LCH and the
other as lymphoma, was not reported. The Kruskal–Wallis
test was used to test any histopathological grading-based
statistically significant difference between the mean ADC
measurements, which revealed no statistically significant
difference between the grade 1, 2, and 3 lesions (P = 0.263).
The highest CR/S ratio was found to be 13.79, the
minimum to be 0.11 (mean: 1.46), and the median to be
0.46. CR/S ratios were classified into the two groups of
high CR/S (above the median value) and low CR/S (below
the median value). The CR/S ratio was recorded to be 2.11
± 3.32 for the IDC (n = 19), 0.55 ± 0.76 for the ILC (n =
10), 1.53 ± 1.62 for the IDC + ILC (n = 4), 0.15 for IDC +
ICC (n = 1), 0.30 for the ICC (n = 2), 3.56 for the medullary
carcinoma (n = 1), 0.44 for the ITC (n = 1), and 0.38 for the
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Table 1. Specificity and sensitivity of threshold ADC value in malignant tissues and subtypes.
ADC 1000
Histological type

Threshold ADC
value, × 10–3 mm2/s

Sensitivity (%)

Specificity (%)

AUC (%)

Malignant lesions

1.260

79.7

81.4

85.7

IDC

1.260

80.8

81.4

87.2

ILC

1.391

88.2

79.5

84.3

IDC: Invasive ductal carcinoma, ILC: invasive lobular carcinoma, ADC: apparent diffusion coefficient.

Figure 1. ROC curves showing high sensitivity for the threshold ADC value in malignant lesions, IDCs, and ILCs.

mucinous carcinoma (n = 1). Due to the disproportional
numeric distribution and prevalence, the chi-square test
revealed no statistically significant relationship of the
CR/S ratios of the histological subtypes of IDC, ILC, and
others in distinguishing between the subtypes (P = 0.48)
(Table 2).
However, the nonparametric Spearman correlation
test revealed a positive correlation between the variables
regarding the relationship between histopathological
grading and the CR/S ratio (P < 0.0001; r = 0.583). In
other words, the CR/S ratio increased in parallel with
the increase in the histopathological grade. The Pearson
correlation test was used to analyze the correlation
between the mean ADC values and CR/S ratio. Mean ADC
value was calculated to be 1.135 ± 0.429 × 10–3 mm2/s in
those with low CR/S ratio (n = 21) and 1.155 ± 0.429 × 10–3
mm2/s in those with high CR/S ratio (n = 18). A positive
correlation was observed between mean ADC values and
CR/S ratio, though not at a statistically significantly level
(P = 0.62; r = 0.08) (Table 3).
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4. Discussion
The only imaging method that, under current conditions,
visualizes cellularity is DWI (9,10). Breast imaging is
generally performed at 1.5 T and high b values, and
the measurement accuracy of the mean ADC values is
observed to increase at 3 T and b values of >850 mm/s
(11,12). Lesions with lower ADC values are observed to
have better contrast in studies conducted on brain tumors
by assigning high b values. This finding indicates that
MRI and DWI are much better in young and high-density
breasts with increased prevalence of ductal carcinoma
in situ (DCIS) (13). In a study where they used b values
of 0 and 700 s/mm2, Kinoshita et al. reported the mean
ADC value of 1.22 ± 0.19 × 10–3 mm2/s of IDC-diagnosed
masses in the DWI scans acquired with single-shot turbo
spin echo (HASTE) sequences (8). In another study where
Reiko et al. (14) evaluated the mean ADC values in the
discrimination of IDC and non-IDC cases, the ADC
value for IDC was found to be statistically significantly
lower than that for non-IDC. In the study conducted by
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Table 2. CR/S ratio and mean ADC values of malignant subtypes.
Histology

CR/S

Mean ADC, ×
10–3 mm2/s

IDC
ILC
IDC + ILC
IDC + ICC
ICC
Medullary carcinoma
Mucinous carcinoma
ITC
Total

2.11 ± 3.32
0.55 ± 0.76
1.53 ± 1.62
0.15
0.30
3.56
0.38
0.44

1.123 ± 0.309
1.073 ± 0.184
0.862 ± 0.219
1.241
0.966
0.845
2.568 ± 0.165
0.927

Total
19
10
4
1
1
1
2
1
39

IDC: Invasive ductal carcinoma, ILC: invasive lobular carcinoma, ICC: invasive
cribriform carcinoma, ITC: invasive tubular carcinoma, CR/S: cellular region/
stroma, ADC: apparent diffusion coefficient.

Table 3. Mean ADC values of low and high ratios of CR/S (P =
0.62) (Pearson correlation analysis, r = 0.08).
CR/S ratio

n (%)

Mean ADC, × 10–3 mm2/s

Low

21 (51.2)

1.135 ± 0.428

High

18 (48.8)

1.155 ± 0.428

Total

39 (100)

CR/S: Cellular region/stroma, ADC: apparent diffusion
coefficient.

Sinha et al. (15), in EPI sequences with b values of 0 and
400 mm2/s, the mean ADC value of the malignant breast
lesions was found to be 1.60 ± 0.36 × 10–3 mm2/s. When
considered together with the results of many other studies,
the study by Sonmez et al. (16) is observed to produce
lower mean ADC values in malignant breast tumors. In the
model study where Rahbar et al. (17) compared contrastenhanced dynamic MRI and DWI in DCIS grading by
using b values of 0 and 600 mm/s, better contrast-to-noise
ratio was observed to be produced at high b values.
In the study of Guo et al. (6), which used EPI sequences
and b values (100, 500, and 1000 s/mm2) similar to the
present study, the authors reported the mean ADC value
of 0.97 ± 0.20 × 10–3 mm2/s in the malignant breast lesions
and the threshold ADC value of 1.30 × 10–3 mm2/s, with
93% sensitivity and 88% specificity. In the study by Luo et
al. (18), the mean ADC value was defined to be 0.87 ± 0.23
× 10–3 mm2/s in malignant lesions and the threshold ADC
value was 1.22 × 10–3 mm2/s, with 88.9% sensitivity and
87.9% specificity. However, in the present study, although

the mean ADC value of the malignant lesions (b = 1000)
was found to be lower for the IDC lesions than the ILC
lesions, no statistically significant difference was found
between the mean ADC values in the discrimination
of subtypes (P = 0.45). The high mean ADC value of
mucinous tumor lesions can be attributed to the brightness
of the mucin content in the T2-weighted MRI. Although
both the present study and that of Lou et al. as well as some
other literature studies produced similar threshold ADC
values for the b value of 1000 s/mm2 for malignant breast
lesions, there are numerical differences in the threshold
ADC values when compared with some other studies (18).
Table 4 presents the differences between the data produced
by the present study and the previous literature data. These
differences can be attributed to the brand of the devices
used and the differences in Tesla power and, particularly,
b values.
As the grade of malignant tumor lesions increases,
the mean ADC value is expected to decrease (18). In the
study by Mami et al. (19) on low-grade DCIS patients,
those with low grades were observed to produce higher
ADC values than those with moderate- and high-grade
DCIS. The study by Razek et al. (1) showed a statistically
significant decrease in mean ADC values with the increase
in the lesion grading of the IDC cases. In a study on brain
tumors, mean ADC value of the low-grade gliomas was
observed to be higher than that of the high-grade gliomas.
Unlike in the literature, the present study produced no
histopathological grade-based statistically significant
relationship between the mean ADC values of the grade
1, 2, and 3 lesions (P = 0.263). This result is estimated to
have resulted from the lesions consisting of heterogeneous
and different subtypes and it is thought that the results
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Table 4. Mean ADC values of malignant lesions in the literature and the present study.
Reference

Sönmez et al. (16)

Method
Sequence

b value

Mean ADC value
Malignant

EPI

0–1000

0.82 ± 0.07

IDC

ILC

-

-

Guo et al. (6)

EPI

0–1000

0.97 ± 0.27

-

-

Luo et al. (18)

EPI

0–1000

0.87 ± 0.23

-

-

Reiko et al. (14)

EPI

0–750

1.12 ± 0.24

1.09 ± 0.23

1.07 ± 0.56

Our study

EPI

0–1000

1.098 ± 0.41

1.078 ± 0.294

1.151 ± 0.340

ADC: Apparent diffusion coefficient, EPI: echoplanar imaging.

will comply with the previous literature results when the
grades of a single subtype are considered.
One of the major prognostic factors of malignant
breast lesions is the histopathological characteristic of the
lesions (20). These characteristics are classified as the size
and grade of the lesion. According to the American Joint
Committee on Cancer (AJCC/UICC) TNM staging system,
7th edition, the Nottingham Histologic Score System
(Elston–Ellis modification of Scarff–Bloom–Richardson
Grading System) is used (20). This system defines the
final grade according to glandular/tubular differentiation,
nuclear pleomorphism, and mitotic activity. Different
parameters are considered in lesion grading of different
organ malignities.
The stromal tissue that surrounds the tumor cells in
malignant breast lesions plays a key role in the development
and behavior of the tumor. In a study in which Kruijf et al.
(21) investigated the relationship between the CR/S ratio
and relapse in triple-negative breast cancer, the life-long
relapse risk was found to be 2.92 times higher for tumors
with more than 50% stromal content compared to those
with a lower stromal content. The literature defines the
stromal content amount as one of the prognostic factors of
primary tumors of colorectal cancer (21). In a study where
Unlu et al. (22) evaluated the prognostic value of the tumor
stromal content in laryngeal cancer, the stromal content was
observed not to be a prognostic factor but was recorded to
be low, as expected, in cases with perinodal invasion. The
analyses made in the scope of this present study by using
the CR/S ratio calculation program proved a statistically
significant relationship between grade and cellularity (P
< 0.0001). There was a positive correlation between grade
and CR/S ratio: high grades were accompanied by high
CR/S ratios. The direct relationship documented by the
literature between histopathological grade and prognosis,
on one hand, and particularly cellularity, on the other, in
neuroectodermal tumors does not apply to most of the
tumors with epithelial origin (21,23). Breast lesions are
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also in the group of tumors with epithelial origin, and
particularly the stromal content, as well as cellularity, has
a significant impact on tumor behavior. For this reason, in
the scope of this study, it may be misleading to establish a
one-to-one relationship between the grade and CR/S ratio
of malignant subtypes of the limited and heterogeneous
study group. Another reason may be consideration by the
pathologist of such criteria as the cell number and nuclear
pleomorphism-atypia in detection of the grade (21). In
conclusion, although the CR/S ratio seems to be quite
helpful in the discrimination of lesions with malignancy
potential, it is not an effective marker in the differentiation
of subtypes of malignant breast lesions currently. In
the present study, the mean ADC value was 1.051 ×
10–3 mm2/s with a CR/S ratio of 3.93 in one case with
histopathologically confirmed IDC + ILC (Figures 2a–2d).
There are only a limited number of literature studies
pointing out the relationship between cellularity and ADC
values. In the study by Koray et al. where the authors
examined the ADC values and cellularity of pediatric
cerebellar tumors by manually counting the cell nuclei
in pathology preparations instead of using an automatic
program, a negative correlation was shown between
cellularity and ADC values (23). However, although
cellularity is shown to be the sole marker that identifies
the diffusion characteristics of the extracellular region
of brain tumors with neuroectodermal origin, other
parameters such as the stromal content amount should be
considered together with cellularity in breast tumors with
epithelial origin (24). Cellularity is directly proportional
to the malignity potential of the tumor in central nervous
system tumors. However, breast tumors are of epithelial
origin, and the cellularity may not always affect the
biological behavior adversely. In the present study, a
positive correlation was observed between the increased
CR/S ratios and the increased ADC values (P = 0.62; r =
0.08). Although these data seem to be the opposite of the
relationship of the mean ADC value with cellularity, there
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a

b

c

d

Figure 2. T1W image and T2W image with fat suppression; BI-RADS 5 lesion with localized lobular and irregular margins (a, b). The
upper outer quadrant of the right breast showing contrast enhancement in the postcontrast series, pharmacokinetic curves showing
type 2 curving (c). Limited diffusion with a mean ADC value of 1.051 × 10–3 mm2/s and CR/S ratio of 3.93 (d). Histopathology: IDC +
ILC, grade 2.
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is no literature study indicating a relationship between the
CR/S ratio and the ADC value of malignant breast lesions.
In this study, since it is reproducible and reliable, automatic
software was used to calculate the CR/S ratio. Although
this study suggests for breast carcinomas that increased
ADC values may be associated with high cellularity and
that high tumor cellularity may be associated with high
grade, these results offer no final prediction about the
biological behavior of the tumor because none of the
aforementioned parameters are independent prognostic
factors themselves. Fluid diffusion in the extracellular
region was expected to be limited and, in turn, the ADC
ratio was expected to decrease as the cellularity increased.
However, the stromal content in the extracellular region
may play a role in diffusion limitation in breast carcinomas.
There are new techniques available; Perou et al.
suggested four intrinsic breast cancer subtypes (luminal-A,
luminal-B, HER2-enriched, triple-negative) that could be
defined at the gene expression level (25). In pathologic
evaluation new techniques and immunohistochemistry
allow us to determine new markers such as hormone
receptor, human epidermal growth factor receptor-type 2
(HER2), and proliferation index. In the literature there are
many indications of subtype differentiation of breast cancer
according to MRI characteristics (26,27). In our study we
have not evaluated ADC values and cellularity values of

breast lesions according to molecular subtypes. This is one
of the limitations of this study. Furthermore, the number
of patients in this study is small. This is another limitation
of our study. By increasing the number of patients and the
classification of lesions according to molecular subtypes,
the results of ADC values and CR/S ratios would provide
us a strong marker in the diagnosis and discrimination of
different subtypes of breast malignant lesions.
In conclusion, ADC and DWI combined with
conventional breast MRI enable prediction at
high sensitivity and specificity to differentiate the
histopathological subtypes of malignant lesions from
normal breast tissue. However, ADC calculation does
not seem to be an alternative of the golden standard of
histopathology in the differentiation of the subtypes. In
addition, the positive correlation between the ADC values
and the CR/S ratio is thought to possibly be used as a
strong marker in evaluation of the stromal component of
lesions.
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